Pulmonary Arterial Hypertension and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Pulmonary Arterial Hypertension (PAH) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pulmonary Arterial Hypertension (PAH) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pulmonary Arterial Hypertension (PAH) Overall Market Size
2.1 Global Pulmonary Arterial Hypertension (PAH) Market Size: 2022 VS 2031
2.2 Global Pulmonary Arterial Hypertension (PAH) Market Size, Prospects & Forecasts: 2019-2031
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pulmonary Arterial Hypertension (PAH) Players in Global Market
3.2 Top Global Pulmonary Arterial Hypertension (PAH) Companies Ranked by Revenue
3.3 Global Pulmonary Arterial Hypertension (PAH) Revenue by Companies
3.4 Top 3 and Top 5 Pulmonary Arterial Hypertension (PAH) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Pulmonary Arterial Hypertension (PAH) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pulmonary Arterial Hypertension (PAH) Players in Global Market
3.6.1 List of Global Tier 1 Pulmonary Arterial Hypertension (PAH) Companies
3.6.2 List of Global Tier 2 and Tier 3 Pulmonary Arterial Hypertension (PAH) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pulmonary Arterial Hypertension (PAH) Market Size Markets, 2022 & 2031
4.1.2 Prostacyclin and Prostacyclin Analogs
4.1.3 SGC Stimulators
4.1.4 ERA
4.1.5 PDE-5
4.2 By Type - Global Pulmonary Arterial Hypertension (PAH) Revenue & Forecasts
4.2.1 By Type - Global Pulmonary Arterial Hypertension (PAH) Revenue, 2019-2024
4.2.2 By Type - Global Pulmonary Arterial Hypertension (PAH) Revenue, 2024-2031
4.2.3 By Type - Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share, 2019-2031
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pulmonary Arterial Hypertension (PAH) Market Size, 2022 & 2031
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Pulmonary Arterial Hypertension (PAH) Revenue & Forecasts
5.2.1 By Application - Global Pulmonary Arterial Hypertension (PAH) Revenue, 2019-2024
5.2.2 By Application - Global Pulmonary Arterial Hypertension (PAH) Revenue, 2024-2031
5.2.3 By Application - Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share, 2019-2031
6 Sights by Region
6.1 By Region - Global Pulmonary Arterial Hypertension (PAH) Market Size, 2022 & 2031
6.2 By Region - Global Pulmonary Arterial Hypertension (PAH) Revenue & Forecasts
6.2.1 By Region - Global Pulmonary Arterial Hypertension (PAH) Revenue, 2019-2024
6.2.2 By Region - Global Pulmonary Arterial Hypertension (PAH) Revenue, 2024-2031
6.2.3 By Region - Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share, 2019-2031
6.3 North America
6.3.1 By Country - North America Pulmonary Arterial Hypertension (PAH) Revenue, 2019-2031
6.3.2 US Pulmonary Arterial Hypertension (PAH) Market Size, 2019-2031
6.3.3 Canada Pulmonary Arterial Hypertension (PAH) Market Size, 2019-2031
6.3.4 Mexico Pulmonary Arterial Hypertension (PAH) Market Size, 2019-2031
6.4 Europe
6.4.1 By Country - Europe Pulmonary Arterial Hypertension (PAH) Revenue, 2019-2031
6.4.2 Germany Pulmonary Arterial Hypertension (PAH) Market Size, 2019-2031
6.4.3 France Pulmonary Arterial Hypertension (PAH) Market Size, 2019-2031
6.4.4 U.K. Pulmonary Arterial Hypertension (PAH) Market Size, 2019-2031
6.4.5 Italy Pulmonary Arterial Hypertension (PAH) Market Size, 2019-2031
6.4.6 Russia Pulmonary Arterial Hypertension (PAH) Market Size, 2019-2031
6.4.7 Nordic Countries Pulmonary Arterial Hypertension (PAH) Market Size, 2019-2031
6.4.8 Benelux Pulmonary Arterial Hypertension (PAH) Market Size, 2019-2031
6.5 Asia
6.5.1 By Region - Asia Pulmonary Arterial Hypertension (PAH) Revenue, 2019-2031
6.5.2 China Pulmonary Arterial Hypertension (PAH) Market Size, 2019-2031
6.5.3 Japan Pulmonary Arterial Hypertension (PAH) Market Size, 2019-2031
6.5.4 South Korea Pulmonary Arterial Hypertension (PAH) Market Size, 2019-2031
6.5.5 Southeast Asia Pulmonary Arterial Hypertension (PAH) Market Size, 2019-2031
6.5.6 India Pulmonary Arterial Hypertension (PAH) Market Size, 2019-2031
6.6 South America
6.6.1 By Country - South America Pulmonary Arterial Hypertension (PAH) Revenue, 2019-2031
6.6.2 Brazil Pulmonary Arterial Hypertension (PAH) Market Size, 2019-2031
6.6.3 Argentina Pulmonary Arterial Hypertension (PAH) Market Size, 2019-2031
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pulmonary Arterial Hypertension (PAH) Revenue, 2019-2031
6.7.2 Turkey Pulmonary Arterial Hypertension (PAH) Market Size, 2019-2031
6.7.3 Israel Pulmonary Arterial Hypertension (PAH) Market Size, 2019-2031
6.7.4 Saudi Arabia Pulmonary Arterial Hypertension (PAH) Market Size, 2019-2031
6.7.5 UAE Pulmonary Arterial Hypertension (PAH) Market Size, 2019-2031
7 Pulmonary Arterial Hypertension (PAH) Companies Profiles
7.1 Actelion
7.1.1 Actelion Company Summary
7.1.2 Actelion Business Overview
7.1.3 Actelion Pulmonary Arterial Hypertension (PAH) Major Product Offerings
7.1.4 Actelion Pulmonary Arterial Hypertension (PAH) Revenue in Global Market (2019-2024)
7.1.5 Actelion Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Pulmonary Arterial Hypertension (PAH) Major Product Offerings
7.2.4 Gilead Sciences Pulmonary Arterial Hypertension (PAH) Revenue in Global Market (2019-2024)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 United Therapeutics
7.3.1 United Therapeutics Company Summary
7.3.2 United Therapeutics Business Overview
7.3.3 United Therapeutics Pulmonary Arterial Hypertension (PAH) Major Product Offerings
7.3.4 United Therapeutics Pulmonary Arterial Hypertension (PAH) Revenue in Global Market (2019-2024)
7.3.5 United Therapeutics Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Major Product Offerings
7.4.4 GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Revenue in Global Market (2019-2024)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Pulmonary Arterial Hypertension (PAH) Major Product Offerings
7.5.4 Pfizer Pulmonary Arterial Hypertension (PAH) Revenue in Global Market (2019-2024)
7.5.5 Pfizer Key News & Latest Developments
7.6 Bayer
7.6.1 Bayer Company Summary
7.6.2 Bayer Business Overview
7.6.3 Bayer Pulmonary Arterial Hypertension (PAH) Major Product Offerings
7.6.4 Bayer Pulmonary Arterial Hypertension (PAH) Revenue in Global Market (2019-2024)
7.6.5 Bayer Key News & Latest Developments
7.7 Arena
7.7.1 Arena Company Summary
7.7.2 Arena Business Overview
7.7.3 Arena Pulmonary Arterial Hypertension (PAH) Major Product Offerings
7.7.4 Arena Pulmonary Arterial Hypertension (PAH) Revenue in Global Market (2019-2024)
7.7.5 Arena Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Pulmonary Arterial Hypertension (PAH) Market Opportunities & Trends in Global Market
Table 2. Pulmonary Arterial Hypertension (PAH) Market Drivers in Global Market
Table 3. Pulmonary Arterial Hypertension (PAH) Market Restraints in Global Market
Table 4. Key Players of Pulmonary Arterial Hypertension (PAH) in Global Market
Table 5. Top Pulmonary Arterial Hypertension (PAH) Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Pulmonary Arterial Hypertension (PAH) Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Pulmonary Arterial Hypertension (PAH) Revenue Share by Companies, 2019-2024
Table 8. Global Companies Pulmonary Arterial Hypertension (PAH) Product Type
Table 9. List of Global Tier 1 Pulmonary Arterial Hypertension (PAH) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pulmonary Arterial Hypertension (PAH) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2022 & 2031
Table 12. By Type - Pulmonary Arterial Hypertension (PAH) Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Pulmonary Arterial Hypertension (PAH) Revenue in Global (US$, Mn), 2024-2031
Table 14. By Application ? Global Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2022 & 2031
Table 15. By Application - Pulmonary Arterial Hypertension (PAH) Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Pulmonary Arterial Hypertension (PAH) Revenue in Global (US$, Mn), 2024-2031
Table 17. By Region ? Global Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2022 & 2031
Table 18. By Region - Global Pulmonary Arterial Hypertension (PAH) Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Pulmonary Arterial Hypertension (PAH) Revenue (US$, Mn), 2024-2031
Table 20. By Country - North America Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2024-2031
Table 22. By Country - Europe Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2024-2031
Table 24. By Region - Asia Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2024-2031
Table 26. By Country - South America Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2024-2031
Table 28. By Country - Middle East & Africa Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2024-2031
Table 30. Actelion Company Summary
Table 31. Actelion Pulmonary Arterial Hypertension (PAH) Product Offerings
Table 32. Actelion Pulmonary Arterial Hypertension (PAH) Revenue (US$, Mn) & (2019-2024)
Table 33. Actelion Key News & Latest Developments
Table 34. Gilead Sciences Company Summary
Table 35. Gilead Sciences Pulmonary Arterial Hypertension (PAH) Product Offerings
Table 36. Gilead Sciences Pulmonary Arterial Hypertension (PAH) Revenue (US$, Mn) & (2019-2024)
Table 37. Gilead Sciences Key News & Latest Developments
Table 38. United Therapeutics Company Summary
Table 39. United Therapeutics Pulmonary Arterial Hypertension (PAH) Product Offerings
Table 40. United Therapeutics Pulmonary Arterial Hypertension (PAH) Revenue (US$, Mn) & (2019-2024)
Table 41. United Therapeutics Key News & Latest Developments
Table 42. GlaxoSmithKline Company Summary
Table 43. GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Product Offerings
Table 44. GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Revenue (US$, Mn) & (2019-2024)
Table 45. GlaxoSmithKline Key News & Latest Developments
Table 46. Pfizer Company Summary
Table 47. Pfizer Pulmonary Arterial Hypertension (PAH) Product Offerings
Table 48. Pfizer Pulmonary Arterial Hypertension (PAH) Revenue (US$, Mn) & (2019-2024)
Table 49. Pfizer Key News & Latest Developments
Table 50. Bayer Company Summary
Table 51. Bayer Pulmonary Arterial Hypertension (PAH) Product Offerings
Table 52. Bayer Pulmonary Arterial Hypertension (PAH) Revenue (US$, Mn) & (2019-2024)
Table 53. Bayer Key News & Latest Developments
Table 54. Arena Company Summary
Table 55. Arena Pulmonary Arterial Hypertension (PAH) Product Offerings
Table 56. Arena Pulmonary Arterial Hypertension (PAH) Revenue (US$, Mn) & (2019-2024)
Table 57. Arena Key News & Latest Developments
List of Figures
Figure 1. Pulmonary Arterial Hypertension (PAH) Segment by Type in 2022
Figure 2. Pulmonary Arterial Hypertension (PAH) Segment by Application in 2022
Figure 3. Global Pulmonary Arterial Hypertension (PAH) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pulmonary Arterial Hypertension (PAH) Market Size: 2022 VS 2031 (US$, Mn)
Figure 6. Global Pulmonary Arterial Hypertension (PAH) Revenue, 2019-2031 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pulmonary Arterial Hypertension (PAH) Revenue in 2022
Figure 8. By Type - Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share, 2019-2031
Figure 9. By Application - Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share, 2019-2031
Figure 10. By Type - Global Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2022 & 2031
Figure 11. By Type - Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share, 2019-2031
Figure 12. By Application - Global Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2022 & 2031
Figure 13. By Application - Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share, 2019-2031
Figure 14. By Region - Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share, 2019-2031
Figure 15. By Country - North America Pulmonary Arterial Hypertension (PAH) Revenue Market Share, 2019-2031
Figure 16. US Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2019-2031
Figure 17. Canada Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2019-2031
Figure 18. Mexico Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2019-2031
Figure 19. By Country - Europe Pulmonary Arterial Hypertension (PAH) Revenue Market Share, 2019-2031
Figure 20. Germany Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2019-2031
Figure 21. France Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2019-2031
Figure 22. U.K. Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2019-2031
Figure 23. Italy Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2019-2031
Figure 24. Russia Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2019-2031
Figure 25. Nordic Countries Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2019-2031
Figure 26. Benelux Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2019-2031
Figure 27. By Region - Asia Pulmonary Arterial Hypertension (PAH) Revenue Market Share, 2019-2031
Figure 28. China Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2019-2031
Figure 29. Japan Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2019-2031
Figure 30. South Korea Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2019-2031
Figure 31. Southeast Asia Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2019-2031
Figure 32. India Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2019-2031
Figure 33. By Country - South America Pulmonary Arterial Hypertension (PAH) Revenue Market Share, 2019-2031
Figure 34. Brazil Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2019-2031
Figure 35. Argentina Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2019-2031
Figure 36. By Country - Middle East & Africa Pulmonary Arterial Hypertension (PAH) Revenue Market Share, 2019-2031
Figure 37. Turkey Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2019-2031
Figure 38. Israel Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2019-2031
Figure 39. Saudi Arabia Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2019-2031
Figure 40. UAE Pulmonary Arterial Hypertension (PAH) Revenue, (US$, Mn), 2019-2031
Figure 41. Actelion Pulmonary Arterial Hypertension (PAH) Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Gilead Sciences Pulmonary Arterial Hypertension (PAH) Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. United Therapeutics Pulmonary Arterial Hypertension (PAH) Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Pfizer Pulmonary Arterial Hypertension (PAH) Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Bayer Pulmonary Arterial Hypertension (PAH) Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Arena Pulmonary Arterial Hypertension (PAH) Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Industry Market Size
